The following table includes registration statements and post-effective amendments that were declared effective by the Securities and Exchange Commission on the most recently completed business day.

The Securities Act of 1933 requires companies offering securities to file a registration statement with the SEC that discloses material facts for investors. The SEC staff reviews registration statements and declares them "effective" if companies satisfy the disclosure rules.

 
 
REGISTRATIONS EFFECTIVE AS OF July 10, 2012 
 
STOCK: 
 
ACCENTIA BIOPHARMACEUTICALS, INC. (ABPI) 
File Number: 333-182376 
Date of Original Registration: 6/27/2012 
Form Type: S-1 
Securities Registered: 1,607,148 Shares Of Common Stock 
Selling Holder: Yes 
 
FREESEAS INC. (FREE) 
File Number: 333-182471 
Date of Original Registration: 6/29/2012 
Form Type: F-1 
Securities Registered: 1,839,721 Shares of Common Stock 
Selling Holder: Yes 
 
 
MIXED SECURITIES: 
 
BROOKFIELD ASSET MANAGEMENT INC (BAM) 
File Number: 333-182092 
Date of Original Registration: 6/13/2012 
Form Type: F-10 
"Securities Registered: $1,000,000,000 in Debt Securities , 
Class A Preference Shares, Class A Limited Voting Shares 
Selling Holder: Yes 
 
Synergy Pharmaceuticals Inc. (SGYP) 
File Number: 333-182271 
Date of Original Registration: 6/21/2012 
Form Type: S-3 
Securities Registered: $250,000,000 in Common Stock, 
Preferred Stock, Warrants and Units. 
Selling Holder: No 
 
 
 

Order free Annual Report for Accentia BioPharmaceuticals, Inc.

Visit http://djnewswires.ar.wilink.com/?link=ABPI or call 1-888-301-0513

Order free Annual Report for Brookfield Asset Management, Inc.

Visit http://djnewswires.ar.wilink.com/?link=BAM or call 1-888-301-0513

Order free Annual Report for Synergy Pharmaceuticals, Inc.

Visit http://djnewswires.ar.wilink.com/?link=SGYP or call 1-888-301-0513